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Abstract
Background: Aleutian mink disease virus (AMDV) is the cause of a chronic immune complex disease, Aleutian
disease (AD), which is common in mink-producing countries. In 2005, implementation of an AMDV eradication
programme in Finland created a need for an automated high-throughput assay. The aim of this study was to
validate an AMDV-VP2 -recombinant antigen ELISA, which we developed earlier, in an automated assay format for
the detection of anti-AMDV antibodies in mink blood and to determine the accuracy of this test compared with
the reference standard (counter-current immunoelectrophoresis, CIEP).
Methods: A blood sampling method based on filter paper 12-strips (blood combs) and a device to introduce these
strips to an ELISA plate for elution of the samples were developed. Blood and serum samples were collected from
761 mink from two farms with low (2%) and high (81%) seroprevalences of AMDV infection in 2008. ELISA sensitivity
and specificity were estimated with a Bayesian 2-test 2-population model that allowed for conditional dependence
between CIEP and ELISA. Agreement between the two tests was assessed with kappa statistic and proportion
agreement.
Results: The sensitivity and specificity of the automated ELISA system were estimated to be 96.2% and 98.4%,
respectively. Agreement between CIEP and ELISA was high, with a kappa value of 0.976 and overall proportion
agreement of 98.8%.
Conclusions: The automated ELISA system combined with blood comb sampling is an accurate test format
for the detection of anti-AMDV antibodies in mink blood and offers several advantages, including improved blood
sampling and data handling, fast sample throughput time, and reductions in costs and labour inputs.
Keywords: Aleutian mink disease virus, Bayesian analysis, Carnivore amdoparvovirus 1, Counter-current
immunoelectrophoresis, Enzyme-linked immunosorbent assay, Sensitivity, Specificity
Background
Aleutian disease (AD), a common and economically signifi-
cant disease in farmed mink (Neovison vison), is caused by
Aleutian mink disease virus (AMDV). The virus belongs to
the recently renamed species of Carnivore amdoparvovirus
1 of the family Parvoviridae [1]. AMDV has a single-
stranded DNA genome and encodes three non-structural
(NS1, NS2, and NS3) and two structural proteins (VP1 and
VP2) [2,3]. The clinical presentation of AMDV infection
varies from a non-progressive and non-persistent disease
to a progressive, persistent, and potentially fatal im-
mune complex disease (so-called classical AD) [2]. Sus-
ceptibility to disease persistence and progression depends
on host and viral factors, and clinical disease is more
severe in Aleutian genotype mink [2]. Infected adult mink
typically develop high concentrations of anti-AMDV anti-
bodies, which can be detected with counter-current
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immunoelectrophoresis (CIEP) from 5 days to 7 weeks
post-infection [2,4].
In 2005, the Finnish Fur Breeders’ Association (FFBA)
implemented an eradication programme to depopulate
AMDV-infected farms and reduce the overall prevalence
of AMDV, and consequently, to improve the health status
of animals and reduce economic losses to farmers caused
by AD. Control and eradication of AMDV on farms
currently depend on serological screening and culling
of anti-AMDV antibody-positive animals, strict sanitary
measures, disinfection of cages and equipment, and intro-
duction of replacement animals from low-risk farms. In
the programme, farms are classified into 5 groups, A-E,
according to AMDV seroprevalence. In group A, test
prevalence must be zero. In groups B, C, and D, within-
farm prevalence should not exceed 1, 2, and 50 positive/
1000 breeding females, respectively. In group E, preva-
lence exceeds 50 positive/1000 breeding females. Fin Fur-
lab (formerly Fur Animal Feed Laboratory) tests 500,000
to 600,000 samples annually for anti-AMDV antibodies.
From 2000 to 2012, the annual mean seroprevalence of all
tested animals ranged between 3.3% and 13.6%.
A need for an automated replacement test for the
traditionally used CIEP method arose due to implemen-
tation of an eradication programme, which led to in-
creased numbers of samples, demand for an additional
labour force, and problems in the availability of the CIEP
antigen. The aim of this study was to automate and val-
idate an enzyme-linked immunosorbent assay (ELISA)
for detecting anti-AMDV antibodies in blood of farmed
mink. Additional objectives were to compare the sensi-
tivities (Se) and specificities (Sp) of ELISA and CIEP,
develop a simple blood sampling method for ELISA,
improve the sample throughput time, and decrease
the labour intensity and costs of testing. Results of this
study are reported according to standards for the report-
ing of diagnostic accuracy studies (STARD) statement [5],
with some modifications for livestock studies [6].
Results
Animals and herds
We sampled and screened for anti-AMDV antibodies on
two mink farms and used both CIEP with capillary blood
samples, and the automated ELISA system with recom-
binant VP2 antigen and filter-paper (FP) strips (designated
blood combs below). Farm 1 (high AMDV seroprevalence)
was situated in Kannus, Central Ostrobothnia, and had
1412 breeding mink, mainly brown, with a small propor-
tion of other colour types. AMDV seroprevalence on this
farm was 81% (in 2007). The farm had a history of clinical
AD, including high mortality and low-quality fur. A total
of 361 mink (25.6%) were sampled on January 9–17, 2008.
All sampled mink were brown, aged 1 to 4 years (median
1 year); 1 was male and 360 were females. Farm 2 (low
AMDV seroprevalence) was situated in Kaustinen, Central
Ostrobothnia, and had 1367 breeding mink, mainly stand-
ard dark, Aleutian, and other colour types. AMDV sero-
prevalence was 2% (in 2007), and the farm had no history
of clinical AD. Samples from 400 mink (29.3%) from farm
2 were taken on January 8–14, 2008; this included 319
black, 39 blackcross, and 42 brown mink. Their ages
ranged from 1 to 4 years (median 2 years). Forty-five were
males and 355 were females. The flow diagram of the
sampling is shown in Figure 1.
Indeterminate and missing results
Results of two ELISA plates (containing altogether 96
samples) were discarded due to problems with the washer.
Fourteen CIEP results were missed as the capillary tube
was lost or broken during sampling or shipping. If either
the ELISA or CIEP sample could not be analysed, the ani-
mal was excluded from the analysis. CIEP results of 3
samples were regarded as unclear positive and 1 as
unclear negative. These samples were included in the ana-
lysis. The ELISA optical density (OD) values for the un-
clear CIEP positive samples were 0.354, 0.616, and 1.056.
Thus, the first was low also in ELISA. The OD value for
the unclear CIEP negative sample was 0.116.
ELISA and CIEP test results and Bayesian estimates of
sensitivity and specificity
Comparisons of the positive and negative results of CIEP
and the automated ELISA system for both farms are
shown in Tables 1 and 2. ELISA results had a mean OD
of 0.086 (range 0.013–1.447) for CIEP-negative and
1.826 (0.115–4.604) for CIEP-positive samples. Overall,
there were nine discrepant results. Three CIEP-positive
samples were negative in ELISA (OD ranging from 0.115
to 0.226) and 6 CIEP-negative samples were ELISA-
positive (OD 0.299–1.447). Most values of discrepant sam-
ples were around the cut-off (0.115–0.461), with only 1
CIEP negative with high ELISA OD (1.447). Histograms of
the distribution of the ELISA test values of farm 1, farm 2,
and total are depicted in Figure 2A–C. The box-and-
whisker plot graph is shown in Figure 3.
The limit of detection of positive serum was 1:10,000 in
ELISA (Figure 4) and 1:100 in CIEP. No cross-reactivity
against mink enteritis virus, Pseudomonas aeruginosa, and
Clostridium botulinum was evident in the ELISA results.
The tests showed almost perfect agreement [7], with a
kappa value of 0.976 (95% confidence interval (CI); 0.961–
0.992), overall proportion agreement of 98.8% (95% CI;
97.9–99.4%), proportion positive agreement of 98.7% (95%
CI; 97.7–99.8%), and proportion negative agreement of
98.9% (95% CI; 97.0–99.4%).
The median Se and Sp of ELISA from the Bayesian
model using informative priors on CIEP test perform-
ance and prevalence (model 2) were 96.2% and 98.4%,
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respectively (Table 3). The probability that ELISA Se
(Sp) was greater than the respective parameters for CIEP
was 58% (55%), indicating comparable accuracy in these
2 populations. A sensitivity analysis using informative
priors on a single parameter only (models 1 and 3) pro-
duced changes in Se estimates of about 3% in both tests,
but virtually no change in Sp. The performance charac-
teristics of ELISA and CIEP were very similar, with few
discordant results. In the high prevalence population,
there were only 6 discordant results (Table 1) and the
discordance was symmetric, which meant that the sensi-
tivities were essentially identical. In the low prevalence
population, the discordance was lower and asymmetric
(3 vs 0) (Table 2), resulting in similar specificities.
Conditional correlations between ELISA and CIEP re-
sults were always positive in models 1–3 (data not shown),
providing statistical evidence (in addition to the biological
argument) that the dependence model was more appro-
priate than a conditional independence model.
Prevalence and predictive values based on ELISA results
In all models, the median true seroprevalence of AMDV
infection in the high prevalence population was estimated
to be between 93% and 96%, and approximately 3% in the
Target population: Finnish 
mink (n=417,022)
Excluded mink (n=200,171): Mink
at farms not sending their samples 
to Fin Furlab or not testing for 
AMDV.
Source population: Mink
at farms sending their 
samples to Fin Furlab 
(n=216,851)
ELISA test 
(n=871)
Excluded samples (n=110): 96 
samples discarded due to problems 
with ELISA washer; 14 samples 
discarded due to missing or broken 
CIEP capillary tube.
Negative (n=412)
CIEP test (n=412)
Positive (n=349)
CIEP test (n=349)
Positive 
(n=340)
Negative 
(n=6)
Unclear 
positive 
(n=3)
Negative 
(n=408)
Unclear 
negative 
(n=1)
Positive 
(n=3)
Figure 1 Flow diagram of the sampling and number of mink undergoing CIEP and automated AMDV-VP2 ELISA tests.
Table 1 Cross-classified results for CIEP and automated
AMDV-VP2 ELISA at farm 1 (high prevalence)
CIEP
Positive Negative Total
ELISA
Positive 328 3 331
Negative 3 27 30
Total 331 30 361
Table 2 Cross-classified results for CIEP and automated
AMDV-VP2 ELISA at farm 2 (low prevalence)
CIEP
Positive Negative Total
ELISA
Positive 15 3 18
Negative 0 382 382
Total 15 385 400
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Figure 2 Histograms of automated AMDV-VP2 ELISA results of CIEP-positive and -negative samples from mink. A. Farm 1 (high
prevalence), 361 samples. B. Farm 2 (low prevalence), 400 samples. C. All 761 samples. X-axis shows the categories (at 0.05 intervals) of net ELISA
optical density (OD) values. Y-axis depicts the number of samples within each category.
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low prevalence population. Prevalence in the high pre-
valence population was lower in models 2 to 3, with a
concomitant increase in test Se (Table 3). The absolute
difference (3%) was considered acceptable, and conclu-
sions about comparative test accuracy did not change. For
the high prevalence (94.3%) population, the median posi-
tive predictive value (PPV) was 99.9% (95% probability
interval (PI); 99.7–99.99%) and negative predictive value
(NPV) 61.2% (95% PI; 17.8–90.0%). For the low prevalence
(2.6%) population, the median PPV was 62.1% (95% PI;
6.5–96.0%) and NPV 99.9% (95% PI; 99.6–99.99%).
Test repeatability
Within-run variability, between-run variability, and be-
tween-serial repeatability for the negative serum measured
as coefficient of variation (CV) were 4% (OD 0.100 ±
standard deviation (SD) 0.004), 9% (0.107 ± 0.010), and 8%
(0.102 ± 0.008), respectively, and for the low-positive
serum 8% (0.425 ± 0.032), 26% (0.532 ± 0.139), and 6%
(0.746 ± 0.043), respectively.
Discussion
In Finland, the CIEP test has been used for screening
anti-AMDV antibodies since 1980. In 2005, the FFBA
implemented a new eradication programme to decrease
AMDV prevalence and help farmers to eradicate the
virus from mink farms. From this arose a need to de-
velop a new, automated, efficient, and highly sensitive
and specific test method. In eradication programmes, a
high Se is needed for screening in order to identify
potent animals and prevent the spread of the virus.
However, in the absence of a confirmatory test, a high
Sp is also required to achieve a high PPV at low preva-
lence, to avoid unnecessary culling and reduce economic
losses (culling valuable breeding animals, loss of group
A status, and effects on animal trade) to farmers caused
by false-positive results.
The CIEP, developed in the 1970s [8], is used for
routine screening of anti-AMDV antibodies in many
countries. Estimated Se and Sp for CIEP vary from 78.7%
to 98.9% and from 90.4% to 100%, respectively [9-12].
Few studies on use of ELISA tests in anti-AMDV anti-
body screening have been reported [9,12-14]. Wright
and Wilkie [9] used a fluorocarbon-activated antigen
and stated that due to the high number of false-negative
results ELISA was not as effective as CIEP as a screening
method. Dam-Tuxen et al. [12] reported results of an
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Figure 3 Box-and-whisker plot graph of AMDV-VP2 ELISA
results for CIEP-positive and -negative samples from mink. The
bottom of the box shows the 25th percentile, the line within the
box indicates the median, and the top of the box shows the 75th
percentile. Ends of the whiskers are at 25th percentile – (1.5 ×
interquartile range) and 75th percentile + (1.5 × interquartile range).
Outliers are indicated as small circles. OD = optical density.
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Figure 4 End-point titration curve of automated AMDV-VP2 ELISA using a high-positive mink serum. The limit of detection of the positive
serum was 1:10,000 in ELISA and 1:100 in CIEP. OD = optical density.
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automated ELISA based on cell-culture derived AMDV-G
antigen (ELISA Danad antigen, Kopenhagen Fur, Glostrup,
Denmark) and dried blood spot cards and concluded that
CIEP and ELISA have comparable performance. Anders-
son et al. [13] compared Se and Sp of two manual ELISA
tests to CIEP. One of the ELISAs was based on the same
recombinant AMDV-VP2 antigen used here and the other
was an ELISA kit based on a traditionally cultured AMDV-
G antigen (Scintilla Development Company LLC, Bath,
PA, USA). The recombinant VP2 ELISA had a high Se, in
contrast to the AMDV-G ELISA kit. Our previous study
[14] focused on development of the recombinant antigen,
showing its antigenicity and optimizing the ELISA method
for diagnostic purposes with a preliminary comparison of
CIEP and ELISA results.
Our findings here on the Se (96.2%) and Sp (98.4%) of
the automated ELISA system were in concordance with
these earlier results [13,14]. The Se and Sp of ELISA and
CIEP did not differ substantially regardless of the selected
model and were similar for both assays. Nine discordant
results were detected between ELISA and CIEP (Tables 1
and 2). These could be caused by differences in the anti-
body detection level, differences in the ability to identify
antibodies against different AMDV strains, cross-reac-
tions, and non-specific precipitin lines in CIEP. Also, dif-
ferences in antigen composition (CIEP uses a whole virus
antigen and ELISA a recombinant VP2 antigen) and anti-
gen cultivation and production techniques could cause
some discrepancies in the results.
Overall, the repeatability of the ELISA was high, with
a CV under 10%, except for the low-positive serum with
a between-run CV of 26%. The higher variability for a
low-positive sample was expected, as a sample at a level
between the cut-off and high-positive value will express
variability more frequently than negative and high-
positive samples. As none of the low-positive values
were below the cut-off value and the assay is used quali-
tatively instead of quantitatively, it was not considered
to be a major problem. Furthermore, in the future this
issue can be controlled by normalizing the data, for in-
stance, by expressing the results as sample-to-positive
control ratio (S/P-ratio).
The probability that a test-positive animal is actually
infected was only 62.1% on the low prevalence farm.
This problem can be minimized by using additional
confirmatory tests for positive reactors (serial testing)
in AMDV-free and low prevalence farms to increase
the Sp and PPV.
To fully utilize the automated system and to avoid the
time-consuming and laborious introduction of serum
from glass capillary tubes to the ELISA plate, a new
blood sampling method, a FP 12-strip (so-called blood
comb) was developed (Figure 5). FP blood sampling was
first introduced by Guthrie and Susi in the 1960s [15]
and has since then been widely used in human medicine
[16]. Various applications also exist in veterinary medi-
cine [17]. However, in earlier ELISA applications an add-
itional elution/dilution step is often needed. The blood
Table 3 Results of the 2-test 2-population Bayesian modelling estimating AMDV-VP2 ELISA sensitivity and specificity
Model Median 95% probability interval
1. CIEP sensitivity/specificity only
ELISA sensitivity 0.945 0.898–0.987
ELISA specificity 0.984 0.953–0.998
CIEP sensitivity 0.945 0.898–0.987
CIEP specificity 0.978 0.945–0.995
Prevalence (high) 0.964 0.912–0.998
Prevalence (low) 0.027 0.002–0.056
2. CIEP sensitivity/specificity and prevalences
ELISA sensitivity 0.962 0.915–0.990
ELISA specificity 0.984 0.953–0.998
CIEP sensitivity 0.961 0.915–0.989
CIEP specificity 0.977 0.945–0.995
Prevalence (high) 0.943 0.903–0.984
Prevalence (low) 0.026 0.003–0.054
3. Prevalences only
ELISA sensitivity 0.977 0.930–0.994
ELISA specificity 0.985 0.954–0.999
CIEP sensitivity 0.979 0.931–0.995
CIEP specificity 0.979 0.946–0.996
Prevalence (high) 0.931 0.895–0.974
Prevalence (low) 0.027 0.003–0.054
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comb described here can be directly introduced to an
ELISA plate for elution of antibodies to the ELISA buffer
without a separate elution/dilution step. The blood comb
has several other benefits. The amount of blood needed is
small, sampling is quick and easy, the samples do not get
mixed up, go missing or get broken, their coding, ship-
ment, and storage is easy, and a centrifugation step is not
needed, unlike for capillaries. Moreover, to speed up the
sample handling and to prevent variation caused by differ-
ences in the elution and incubation times of the samples,
a device that introduces the blood combs to the ELISA
plate was developed (Figure 6). This new blood sampling
method also enables the pooling of several samples
(by placing several combs into one row of wells), es-
pecially from AMDV-free farms, lowering the costs of
testing.
The introduction of the automated ELISA for the
screening of anti-AMDV antibodies in the current testing
laboratory in Finland (Fin Furlab) in 2008 has increased
testing capacity and decreased sample throughput time
for large batches. Although new investments had to be
made, the savings, especially from labour costs, have
outweighed the costs. Previously, CIEP results were
read visually and data were stored in a paper format.
In the automated ELISA system, the robot software calcu-
lates and presents the positive and negative results in a
Figure 5 Photograph of the filter paper blood comb. The blood comb is used for the blood sampling of mink in the automated AMDV-VP2
ELISA system. Twelve mink can be sampled with one comb. Except for the tips, the combs are coated with a thin film to prevent the comb
absorbing dilution buffer. On the upper part of the comb, there is room for farm identification, date, and serial number.
Figure 6 Photograph of the device utilized in the automated AMDV-VP2 ELISA. The device introduces eight blood combs simultaneously
to an ELISA plate for the elution of antibodies.
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spreadsheet format and stores them for further analysis.
Another advantage is the unrestricted availability of the
(in-house) recombinant VP2 antigen [14].
Conclusions
Our aim was to automate and validate an ELISA system
for detecting anti-AMDV antibodies in the blood of farmed
mink. This automated ELISA system based on Finnish re-
combinant VP2 antigen and blood comb sampling was
compared with manual CIEP with traditionally cultivated
(Danish Danad) antigen and glass capillary sampling. The
automated ELISA system described in this study is a
highly sensitive and specific test for the serodiagnosis of
AMDV infection, and it offers several advantages, includ-
ing improved and simpler blood sampling and data hand-
ling, fast sample throughput time, and reductions in costs
and labour intensity. The automated ELISA system has
potential utility for demonstration of freedom from AMDV
infection on mink farms or in individual animals, for facili-
tating AMDV eradication on infected farms, and for esti-
mation of within-farm seroprevalence of AMDV.
Methods
Animals and herds
Study sampling frame
Mink farming in Finland is concentrated in the regions of
Ostrobothnia, North, South, and Central Ostrobothnia of
western Finland, where 95% of mink farms are situated.
The target population of this study was Finnish farmed
mink and the source population was mink from farms
sending their anti-AMDV antibody screening samples to
Fin Furlab. The study sample comprised a convenience
sample from mink on farms willing to cooperate in the
study. The seroprevalence and distribution of AMDV in
the target population were unknown, as all farms do not
test (52% of farms tested in 2007), but are suspected to be
higher than in the source population (7.2% in 2007), as
approximately 54% of tested farms were in group A that
year. A flow diagram of the sampling is shown in Figure 1.
Selection of animals and herds
Two farms were selected among eligible farms meeting the
inclusion criteria: farms with either low or high AMDV
seroprevalence, breeding mink representing different ge-
notypes and having different clinical presentations of AD
(from non-progressive and non-persistent to progressive
and persistent) in the year before sampling, and mink vac-
cinated against mink enteritis virus, haemorrhagic pneu-
monia caused by Pseudomonas aeruginosa, and botulism.
Sampling protocol and study design
Blood samples were collected during a routine screening
for anti-AMDV antibodies by toenail cutting by a profes-
sional sample collector (Tarja Hinkkanen, FFBA), who
took both the glass capillary tube (80 μl of blood) and
blood comb (3 μl of blood is expected to saturate each
comb) samples (Figure 5). Both samples were taken at
the same time from each animal. Blood comb samples
were air-dried prior to transportation. Samples were
transported at ambient temperature to Fin Furlab the
same day, the capillaries were centrifuged, and both
samples were stored at +4°C. The following day, the
blood combs were analysed with ELISA and the sera
from the glass capillaries with CIEP.
Sample collection was planned before the ELISA and
CIEP tests were performed (prospective study), and cross-
sectional sampling with complete verification with the
reference test was done.
Test methods
CIEP - the reference standard
Although an imperfect reference standard, the CIEP
test was selected because it was the only commercially-
available test for large-scale diagnostics in mink globally
and it has long been used for serological screening of
AMDV. CIEP was performed using a commercial antigen
and following the manufacturer’s instructions (Antigen
Laboratory of the Research Foundation of the Danish Fur
Breeders’ Association, Glostrup, Denmark). For a detailed
description of the method, see Cho and Greenfield [18].
Results for CIEP were expressed as positive, negative, or
unclear negative/positive. CIEP tests were performed and
the results read by one co-author (ME) and a laboratory
analyst (Pia Söderback), with 20 and 10 years of experi-
ence, respectively, with the assay.
The automated ELISA system
The ELISA method and production of recombinant VP2
antigen in insect cells have been previously described by
our group [14]. This ELISA method was applied with
some modifications: automation and robotics were used
(see below), and blood samples were taken with a newly
developed sampling method with a FP blood comb (see
below and Figure 5). Blood combs were introduced to a
96-well ELISA plate containing 100 μl of dilution buffer,
soaked for 2 min, after which the combs were discarded
and the plate was incubated at room temperature for
1 h. A single sample was collected and measured from
each animal, and results were calculated as net OD
values (mean OD for two blank wells was subtracted
from the raw OD value). Each plate contained duplicates
of negative and positive controls and blank wells (con-
taining all reagents except blood). The negative control,
a serum of a known AMDV-negative (tested with Western
blot, CIEP, and manual ELISA) mink, was diluted to 1:4
in dilution buffer. The positive control, a serum of an
AMDV-positive (tested with PCR, CIEP, and manual
ELISA) mink, was diluted to 1:300. Three microlitres of
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the diluted control serums were pipetted to the control
combs, air-dried, and used in the ELISA test the same
day. Control sera were stored at −20°C in 500 μl (nega-
tive) and 100 μl (positive) aliquots, thawed prior to use,
and subsequently stored at +4°C until finished. The
ELISA cut-off (0.248) was set to a point that gave max-
imal values for both Se and Sp calculated with EpiTools
[19] using receiver operating characteristics (ROC)
curve analysis. ELISA tests were done by two co-authors
(ME and PA) with 12 months of experience with the assay.
The laboratory personnel were aware of source farm iden-
tity. The CIEP and ELISA tests were run simultaneously,
thus, personnel were unaware of the results of individual
animals. Histograms of the ELISA results were generated
with Excel 2010 (Microsoft Corp., Redmond, WA, USA)
and the box-and-whisker plot graph with EpiTools [19].
A Cat X robot, Wellwash AC washer, three Multidrop
384 dispensers, and Multiscan Ascent EX spectropho-
tometer were supplied by Thermo Labsystems (Vantaa,
Finland). The following steps were automated: coating of
plates with prediluted antigen, dispensing the dilution
buffer for samples, washing, dispensing of prediluted con-
jugate, 3,3’,5,5’ –tetramethyl benzidine and stopping solu-
tion (0.5 M H2SO4), reading, raw data capture, and after
implementation of the cut-off also categorizing, present-
ing, and storing negative and positive results. The auto-
mated ELISA system was programmed using the software
Polara 2.3.
A new system, blood combs (Figure 5), for collecting
the blood samples and introducing them to the ELISA
plate was developed. The blood combs were made from
filter paper (Tervakoski Oy, Tervakoski, Finland).
A device (Figure 6) that introduces 8 blood combs
simultaneously was manufactured by CNC-Tekniikka Oy
(Vaasa, Finland).
Statistical methods
For estimation of an approximate sample size in a 2-test
2-population Bayesian model, we first assumed that each
population would have 100% or 0% AMDV infection, that
a conservative estimate of ELISA Se and Sp would be 90%
(estimates from [13] and [14] were at least 97% for both
parameters), and that the estimate would have an error
margin of 5% with 95% confidence. Based on a normal
approximation to the binomial, the sample size for esti-
mating Se and Sp was 138 in both the 100% and 0% popu-
lations. To account for test prevalence information from
2007 on the 2 study farms (81% and 2%), we targeted
sample sizes of approximately 400 per population.
Analytical Se was estimated with end-point dilution of
the positive control serum. The serum was tested in
serial dilutions (2 replicates/dilution) in both ELISA and
CIEP. Six 10-fold dilutions ranging from 1:10 to 1:106
were used. The detection limit for the ELISA test was
set to a dilution that yielded positive results on replicates
(above the cut-off point). Analytical Sp against other path-
ogens present in mink was assessed from cross-reactivity
against mink enteritis virus, Pseudomonas aeruginosa, and
Clostridium botulinum by testing vaccinated animals. The
ELISA test’s ability to identify antibodies against different
AMDV strains circulating in Finland has been reported
previously [14,20].
Agreement between the two tests was assessed with
EpiTools [19] by calculating kappa statistic and proportion
agreements (overall, positive, and negative). Ninety-five
percent confidence intervals for proportion agreement
were calculated with EpiTools using Jeffreys interval [21].
Se and Sp were estimated with a 2-test 2-population
Bayesian model that allowed for conditional depend-
ence between CIEP and ELISA results, as described
in Georgiadis et al. [22]. The model was run in WinBUGS
1.4.3 [23] using code described in Branscum et al. [24] and
available elsewhere [25]. The 2-test 2-population depend-
ence model requires informative prior data on two param-
eters to ensure identifiability. We used data on prevalence
in the two populations from 2007 and the expert opinion
of the first author based on previous studies about the Se
and Sp of CIEP to derive informative beta priors (Table 4.)
Non-informative (beta (1,1)) priors, which allowed all
values between 0 and 1 to have equal probability, were
used for other model parameters. After discarding the first
5000 samples as burn-in, we used the next 50,000 iterates
for inferences about Se, Sp, and prevalence. We used
the STEP function in WinBUGS to estimate the prob-
ability that the Se (Sp) of ELISA was greater than the Se
(Sp) of CIEP. Model convergence was assessed by visual
Table 4 Informative beta priors used in the estimation of AMDV-VP2 ELISA sensitivity (Se) and specificity (Sp) with a
2-test 2-population Bayesian model
Parameters Most probable value 95% sure that at least 95% sure that less than Beta prior
Prevalence
Farm 1 80% 50% 7.55, 2.64
Farm 2 2% 20% 1.30, 15.80
ELISA
Se 99% 50% 4.40, 1.03
Sp 97% 50% 4.58, 1.11
CIE
Se 80% 50% 7.55, 2.64
Sp 95% 50% 4.77, 1.20
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inspection of trace plots and running three chains from
dispersed initial values. Predictive values and 95% PI
were calculated for the high and low prevalence popula-
tions using the model with informative priors on CIEP
accuracy and prevalences.
Within-run, between-run, and within-serial repeatability
variability was assessed by using 1 negative, 1 low-positive
mink serum, and 3 different batches of antigen. Negative
and positive sera were diluted and handled as described
above for the control sera. Within-run variability was cal-
culated for each serum from 4 replicates on a single plate.
Duplicates of each serum were analysed from 20 runs on
5 different days to assess the between-run variability.
Within-serial repeatability was tested from duplicates of
each serum against 3 different batches of antigen. The
variability with ELISA quantitative outcome was estimated
using CV% (SD ÷ mean × 100%). An evaluation of ELISA
reproducibility was not performed because the Fin Furlab
was the only laboratory using this ELISA test at the time
of the study.
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